Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BOD1L
REST API REST API
Homo sapiens
BOD1L is differentially expressed in 188 experiments: 82 organism parts: kidney, pancreas, ... (80 more);, 79 disease states: normal, control, ... (77 more);, 74 cell types 262 cell lines 22 compound treatments and 58 other conditions.
Synonyms KIAA1327, FAM44A, FLJ33215
Orthologs ENSCING00000016435 (Ciona intestinalis)   ENSCING00000013405 (Ciona intestinalis)   ENSGALG00000014919 (Gallus gallus)   BOD1L (Danio rerio)   Bod1l (Mus musculus)   ENSGALG00000014522 (Gallus gallus)   A6QQK0_BOVIN (Bos taurus)   bod1l (Xenopus laevis)   XM_536235.2 (Canis familiaris)   ENSCAFG00000015391 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding
UniProt Accession Q8NFC6, F8WDD0
Search EB-eye ENSG00000038219
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-GEOD-26672, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-19639, E-GEOD-4219, E-GEOD-3202, ... (26 experiments)

Factor Value U/D Experiments
MCF-7
3
 E-GEOD-19639, E-GEOD-20081, E-GEOD-5823
CCRFCEM
2
 E-GEOD-24147, E-MTAB-37
HepG2
2
 E-GEOD-21154, E-GEOD-7307
K562
2
 E-GEOD-24147, E-MTAB-37
U87
2
 E-GEOD-20089, E-MEXP-903
NCIH1048
1
 E-MTAB-37
256 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-13909, ... (35 experiments)

Factor Value U/D Experiments
CD4+ T cell
2
 E-GEOD-16190, E-AFMX-5
human embryonic stem cell
2
 E-GEOD-20033, E-GEOD-18147
stromal cell
2
 E-MEXP-2034, E-GEOD-1460
fetal RPE
1
 E-GEOD-18811
BDCA1+ dendritic cell
1
1
 E-TABM-34
primary T lymphocytes
1
 E-GEOD-13909
68 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-2069, E-MEXP-2280, ... (38 experiments)

Factor Value U/D Experiments
adrenocortical carcinoma
2
 E-TABM-311, E-GEOD-10927
prostate carcinoma
2
 E-MEXP-2034, E-MTAB-37
control
1
2
 E-GEOD-21912, E-GEOD-16363, E-GEOD-16728
FKRP mutation
1
 E-GEOD-3307
gastric carcinoma
1
 E-MTAB-37
ovarian carcinoma
1
 E-MTAB-37
73 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-3284, E-GEOD-15205, E-TABM-782, E-GEOD-7216, ... (12 experiments)

Factor Value U/D Experiments
none
2
3
 E-GEOD-20719, E-TABM-782, E-GEOD-5230, E-GEOD-5099, E-GEOD-7307 ... (5 experiments)
interleukin-24 (Homo sapiens)
1
 E-GEOD-7216
NaOH
1
1
 E-MEXP-2590
unknown
1
 E-GEOD-7307
Cxcl12
1
1
 E-GEOD-7307
TGF
1
 E-GEOD-15205
16 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
 E-GEOD-19519
tunicamycin
1
 E-GEOD-19519
thapsigargin
1
 E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21589, E-GEOD-16363, E-GEOD-18995, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Date of sample preparation and hybridisation
studied in E-GEOD-22541

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-MEXP-2280, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-4086

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, E-MTAB-108, ... (6 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-TABM-868, E-TABM-601, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-20504, E-GEOD-9764, ... (7 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-MEXP-2657, E-GEOD-16363, ... (26 experiments)

Infection
studied in E-GEOD-12254, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-19703, E-GEOD-1657

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-15811, E-GEOD-18791

RNAi
studied in E-MEXP-1857

Sample preparation
studied in E-GEOD-12710

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-15799, ... (6 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-4922

Processing time: 0.291 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM